In 2023, the U.S. uveitis treatment market was valued at USD 0.71 billion and is forecast to grow to USD 1.44 billion by 2032, reflecting a CAGR of 8.09% during the forecast period. The U.S ...

Dilated pupils in cats can be a sign of iris atrophy or a more serious underlying condition. Here’s how to know when to seek ...

SNS Insider Reveals Strategic Outlook for the U.S. Uveitis Treatment Market—Valued at USD 0.71 Billion in 2023—With the Nation Poised to Maintain North American Dominance Amid Rising Adoption of ...

The two-dose vaccine has been shown to have benefits beyond just developing shingles, although that alone should be impetus ...

More than half of all patients with uveitis develop sight threatening complications related to their disease, and up to 35% of patients suffer severe visual impairment. [1, 2] Uveitis and its ...

Active Biotech (NASDAQ Stockholm: ACTI) today provided a status update of its development programs with laquinimod in inflammatory eye disorders and tasquinimod with the core ...

Roivant Sciences' 44% return highlights potential in its pipeline and partnerships. I maintain a cautious stance on RIOV ...

Curious about the seductive allure of changing your eye colour forever? Discover the risks and alternatives that could save your vision while still letting you express your style. Dive into the ...

Cataracts, often associated with older adults, are increasingly diagnosed in younger individuals due to factors like genetics, trauma, lifestyle choic ...

The hazard of the progression of intermediate age-related macular degeneration (iAMD) was higher in those whose complement pathways were not regulated.